Singulair Tablet, Chewable
Product Images NDC 78206-170

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Singulair (NDC 78206-170). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Organon Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Of Figure 1 (Singulair 01)

FDA Label Image

Image Of Montelukast Sodium Chemical Structure (Singulair 02)

FDA Label Image

Image Of Figure 2 (Singulair 03)

FDA Label Image

Principal Display Panel (4 mg Packet Carton)

FDA Label Image

Principal Display Panel (4 mg Tablet Bottle Label)

Principal Display Panel (4 mg Tablet Bottle Label)
This is the description: Chewable Singulair tablets with montelukast sodium for pediatric patients between the age 2-5 years who suffer from asthma and allergic rhinitis. The package contains 30 chewable tablets (4mg) with an NDC code of 78206-170-01. Each tablet contains 4.2mg of Montelukast Sodium, equivalent to 4 mg Montelukast. The medication guide should be dispensed to every patient, and phenylketonurics should be cautious as the product contains 0.674mg of phenylalanine. The could not recognize the last words of the text, hence it is not available.*
FDA Label Image

Principal Display Panel (5 mg Tablet Bottle Label)

Principal Display Panel (5 mg Tablet Bottle Label)
Singulair chewable tablets containing 5mg of Montelukast Sodium are intended for pediatric patients aged 6-14 who suffer from asthma and allergies, and is available in a 30-tablet pack identified by the GTIN 00378206173010. The tablets must be dispensed with a medication guide and should be stored in controlled temperatures between 20°C to 25°C (68°F to77°F) with protection from moisture and light. The packaging label warns against phenylketonurics which contains phenylalanine at 0.842mg per tablet. The instructions specify a serialization barcode, serial number, expiry, and lot.*
FDA Label Image

Principal Display Panel (10 mg Tablet Bottle Label)

Principal Display Panel (10 mg Tablet Bottle Label)
Singulair is a medicine in the form of tablets containing Montelukast Sodium as the active ingredient. The tablets are recommended for adults ages 15 and older. Each tablet contains 10 mg Montelukast Sodium. The medicine should be stored at room temperature in its original package to protect it from moisture and light. The recommended dosage should be obtained from the prescribing information. The GTIN number for this medication is 00378206172013. The NDC number is 78206-172-01. There is also a 2D serialization barcode, which contains information on the serial number, lot number, and expiry.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.